To Investigate the Role of Upstream High Dose Statin in STEMI



Status:Completed
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:25 - 90
Updated:10/7/2018
Start Date:June 2009
End Date:June 2010

Use our guide to learn which trials are right for you!

A Double Blinded Randomized Placebo Controlled Study: To Investigate the Role of Upstream High Dose Statin Treatment in Patients With ST Segment Elevation Myocardial Infarction

This is a double-blinded randomized placebo controlled trial investigating the role of
upstream 80mg Atorvastastin-calcium in patients undergoing percutaneous intervention for
acute STEMI.


Inclusion Criteria:

1. Any patient of 25 to 90 years of age admitted or transferred to Western Pennsylvania
Hospital or Allegheny General Hospital with a diagnosis of STEMI undergoing emergent
percutaneous intervention (PCI) to the culprit coronary artery. STEMI is defined as
greater than 1mm ST segment elevation on electrocardiogram.

2. Elevated cardiac biomarkers (troponin-T > 0.03ng/ml, CKMB>5ng/mL, or ck>170 U/l).

Exclusion Criteria:

1. Known history of liver disease defined as cirrhosis, alcoholic liver disease, Non
alcoholic steatohepatitis, hepatitis or any causes of liver failure.

2. Renal failure with creatinine >3mg/dL

3. Known history of liver or muscle disease such as rheumatologic myopathies, history of
myositis, hepatitis, and hepatic cancer.

4. Cardiovascular arrest and shock.
We found this trial at
2
sites
320 E North Ave
Pittsburgh, Pennsylvania 15212
(412) 359-3131
Allegheny General Hospital At Allegheny General Hospital, our physicians and healthcare staff have earned an...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
4800 Friendship Ave
Pittsburgh, Pennsylvania 15224
(412) 578-5000
Western Pennsylvania Hospital Featuring 308 private patient beds, West Penn Hospital has served Bloomfield and...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials